2nd Quarter - Report

W STRATEGIES, LLC for ABBOTT LABORATORIES

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Educated staff about maintaining strong Intellectual Property provisions in the TransPacific Partnership Agreement.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

Patent Reform H.R. 1249 - America Invents Act of 2011

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1249 (112th)

Health Issues HCR

Monitoring the implementation of the Patient Protection and Affordable Care Act, including provisions related to comparative effectiveness research and a regulatory pathway for biosimilars. H.R. 5 - The Health Act. Educated staff about issues concerning the 510(k) device approval process. S. 17 - Medical Device Access and Innovation Act. H.R. 436 - Protect Medical Device Innovation Act.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 436 (112th), H.R. 5 (112th), S. 17 (112th)

Medicare/Medicaid MMM

Medicare and Medicaid FAST Act. Outreach and education to repeal the Independent Payment Advisory Board. H.R. 452 - Medicare Decisions Accountability Act of 2011. Education on the importance of maintaining the competitive elements of the Part D prescription drug program and to oppose efforts to impose mandatory government rebates in that program.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 452 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.